Clarivate buys SequenceBase to expand life sciences expertise
IP services company Clarivate Analytics has acquired patent sequence information provider SequenceBase to expand its search and analysis capabilities for the life sciences IP market.
New Jersey-based SequenceBase provides patent sequence information and search technology to the biotech, pharmaceutical and chemical industries.
In an announcement published today, September 9, Clarivate said that the acquisition will deliver an expanded solution to the fast-growing biologics market. The deal closed on August 29 for an undisclosed amount.
Dan Videtto, president of Derwent (a Clarivate Analytics company), said: “The acquisition confirms our commitment to the IP life sciences community and will allow us to better serve our customers’ growing needs for high quality, intuitive solutions for sequence-oriented patent research.”
The buy complements Derwent’s Geneseq database, which Clarivate said is the only database to provide annotated analysis to simplify searching and identification of biological sequences covered in patents from more than 50 patent issuing authorities.
Through the combination of SequenceBase’s platform and the Geneseq database, customers can now better understand the sequence landscape, “enabling them to quickly assess patentability, identify potential infringing patents and track competitor activities”, added Videtto.
Martin Goffman, president and CEO of SequenceBase, added: “The combination of SequenceBase’s user-friendly search interface and sequence data with Derwent’s curated and enriched databases will improve the workflow of biologic researchers and IP professionals around the world.”
In January this year, Clarivate announced its plan to merge with Churchill Capital Corp, a public investment company, in a deal that valued the combined company at $4.2 billion.
Clarivate was formed in October 2016 when Thomson Reuters sold its Intellectual Property & Science business to Onex Corporation and Baring Private Equity Asia.
Last year, in October, Clarivate bought TrademarkVision, an Australian company that uses artificial intelligence to conduct visual trademark searches. The move came less than a month after Clarivate sold its IP Management division, which oversees payment and renewal processes for patents and trademarks, to rival CPA Global.
Did you enjoy reading this story? Sign up to our free newsletters and get stories like this sent straight to your inbox.
